In Vivo Non-Clinical Studies

Jerrycret6808 Jan, 2024Technology

Biosimilars - An Additional Opportunity for Patients Non-clinical studies is a critical stage in the drug development. As required by several regulatory agencies, it is essential to demonstrate the biosimilar product matches its innovator products in biological similarities including quality, efficacy and safety before initiating any clinical studies.